Therefore, our data indicates that CUL5 is a potential therapeutic target for virus-induced asthma exacerbations, and further research is required to validate its role in human and investigate the clinical application of IFN-β in treating asthma exacerbations. This evidence concerns the gene CUL5 and asthma.